13F Data
13F filer · CIK 942257

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

London, X0 · filing since Q4 2016 · last filing Nov 14, 2023
Reported value
$296.8M
$-31.7M vs prior
Positions
65
New / sold out
9 / 5
Added / reduced
18 / 13
Turnover
24.3%
buys $76.1M · sells $91.5M
Top-10 weight
47.8%

Biggest buys vs Q2 2023

ChangeSecurityShares changeChange %Est. trade value
AddedBIOMARIN PHARMACEUTICAL I+95,000+162.0%+$8.4M
AddedUNIQURE N.V. COM EUR0.05+1,226,000+7909.7%+$8.2M
AddedBIOGEN INC COMMON STOCK+29,200+265.5%+$7.5M
AddedINTRA-CELLULAR THERAPIES+141,000+79.7%+$7.3M
AddedGILEAD SCIENCES INC COMMO+89,000+61.6%+$6.7M
AddedULTRAGENYX PHARMACEUTICAL+170,000+212.4%+$6.1M
AddedAMYLYX PHARMS.+270,000+1080.0%+$4.9M
AddedAURINIA PHARMACEUTICALS I+467,000+81.4%+$3.6M
NewASTRAZENECA PLC SPONSORED+46,500–+$3.1M
NewCRISPR THERAPEUTICS AG CO+63,000–+$2.9M
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q2 2023

ChangeSecurityShares changeChange %Est. trade value
ReducedREGENERON PHARMACEUTICALS-18,153-67.2%$-14.9M
Sold outAPELLIS PHARMS.-129,700-100.0%$-11.8M
ReducedAMGEN INC COM-38,000-32.4%$-10.2M
ReducedHarmony Biosciences Holdi-256,000-44.9%$-8.4M
ReducedALNYLAM PHARMACEUTICALS I-44,800-54.9%$-7.9M
Sold outHORIZON THERAPEUTICS-67,000-100.0%$-6.9M
Sold outTRAVERE THERAPEUTICS INC-441,019-100.0%$-6.8M
ReducedNEUROCRINE BIOSCIENCES IN-40,000-58.1%$-4.5M
ReducedUNITED THERAPEUTICS CORP-18,800-35.6%$-4.2M
ReducedAKERO THERAPEUTICS INC CO-60,000-76.4%$-3.0M
8 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2016: $222.0MQ1 2017: $261.2MQ2 2017: $263.2MQ3 2017: $256.9MQ4 2017: $283.6MQ1 2018: $256.3MQ2 2018: $260.4MQ3 2018: $210.4MQ4 2018: $161.1MQ1 2019: $270.7MQ2 2019: $269.7MQ3 2019: $216.4MQ4 2019: $277.6MQ1 2020: $219.4MQ2 2020: $300.8MQ3 2020: $309.8MQ4 2020: $366.1MQ1 2021: $378.1MQ2 2021: $378.8MQ3 2021: $414.6MQ4 2021: $448.9MQ1 2022: $414.7MQ2 2022: $9.6MQ3 2022: $311.9MQ4 2022: $323.8MQ1 2023: $358.4MQ2 2023: $328.5MQ3 2023: $296.8M
Q4 2016Q3 2023

Holdings · Q3 2023

#SecuritySharesValueWeight
1AMGEN INC COMCOM79,246$21.3M7.17%
2INCYTE CORP INC COMCOM358,454$20.7M6.97%
3GILEAD SCIENCES INC COMMOCOM233,584$17.5M5.90%
4INTRA-CELLULAR THERAPIESCOM317,856$16.5M5.57%
5BIOMARIN PHARMACEUTICAL ICOM153,656$13.6M4.58%
6SUPERNUS PHARMACEUTICALSCOM426,500$11.8M3.96%
7VERA THERAPEUTICSCL A758,355$10.4M3.50%
8BIOGEN INC COMMON STOCKCOM40,200$10.3M3.48%
9Harmony Biosciences HoldiCOM314,500$10.3M3.47%
10MIRATI THERAPEUTICS INC CCOM216,000$9.4M3.17%
55 more rows. Subscribe for $29/month to see every row, download the data and use the API.